Newsgather

drugs

Stable168 articles16 sourcesDernière mise à jour: 1 sa önce

Derniers articles

Britain's Debate on Rejoining the EU: A Solipsistic Approach
En développement
Politique·1 sa önceRésumé IA

Britain's Debate on Rejoining the EU: A Solipsistic Approach

As the 10th anniversary of Brexit approaches, Britain debates rejoining the EU, focusing on economic benefits and political feasibility. However, the discussion largely ignores the perspectives of other European nations and the EU's own priorities, such as Ukraine and global economic challenges. While some UK politicians advocate for rejoining, the EU has other candidates and a minority who may not welcome Britain back.

G
Guardian Business
India's Growing Out-of-Pocket Healthcare: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance
En développement
Business·9 sa önceRésumé IA

India's Growing Out-of-Pocket Healthcare: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance

Demand for weight-loss drugs, cosmetic procedures, and wellness treatments is driving out-of-pocket healthcare expenses in India. Most of these, like Botox and anti-obesity drugs, are not covered by standard health insurance unless medically necessary, experts advise understanding policy exclusions and avoiding EMIs for elective treatments.

E
Economic Times
India's Growing Out-of-Pocket Healthcare Expenses: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance
En développement
Business·11 sa önceRésumé IA

India's Growing Out-of-Pocket Healthcare Expenses: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance

Demand for weight-loss drugs, cosmetic procedures, and wellness treatments is driving out-of-pocket healthcare spending in India. Most of these interventions, like Botox and anti-obesity drugs, are not covered by standard health insurance unless medically necessary. Experts advise reviewing policy exclusions and avoiding EMIs for elective treatments.

E
Economic Times
Drug Repurposing: From Diabetes to Weight Loss and Beyond
En développement
Santé·3 g önceRésumé IA

Drug Repurposing: From Diabetes to Weight Loss and Beyond

The article explores drug repurposing, highlighting GLP-1 agonists like Ozempic and Wegovy, initially for diabetes, now used for weight loss, cardiovascular health, and more. It also discusses COVID-19 treatments like dexamethasone and baricitinib, and historical examples like raloxifene, thalidomide, BCG vaccine, and Viagra, emphasizing both the benefits and potential risks of using drugs for unapproved conditions.

D
Deutsche Welle